7374

    532531

    STAR

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    STRIDES PHARMA SCI LTD Share Price Today

    STRIDES PHARMA SCI LTD is currently trading at ₹1003.8, up by ₹6.59 from the previous close. The stock touched an intraday high of ₹1019.70 and a low of ₹991.00 during the latest trading session. Over the past one year, STRIDES PHARMA SCI LTD has delivered a return of 25.74%, while the stock has declined 11.02% in the last one month.

    STRIDES PHARMA SCI LTD performance

    Today’s low Today’s high
    ₹ 991.00 ₹ 1019.70
    ₹ 1003.80
    52 week low 52 week high
    ₹ 768.65 ₹ 1231.00
    ₹ 1003.80
    Open Price ₹ 998.30
    Prev. Close ₹ 997.20
    Volume (Shares) 260563.00
    Total traded value ₹ 2615.53
    Upper Circuit ₹ 1196.60
    Lower Circuit ₹ 797.80
    info

    Investment Returns

    Over 1 Month -11.02% Over 3 Months -12.46% Over 6 Months 13.28% Over 1 Year 25.74%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    STRIDES PHARMA SCI LTD fundamentals


    • Market cap (Cr) 9,252.30
    • P/E Ratio (TTM) 38.16
    • Beta 0.61
    • Book Value / share 356.23
    • Return on equity 2.27%
    • EPS (TTM) 19.54
    • Dividend yield 0.50%
    • Net profit/quarter (Cr) 72.93
    info icon alternate text
    • Market cap (Cr) 9,282.30
    • P/E Ratio (TTM) 38.16
    • Beta 0.57
    • Book Value / share 356.23
    • Return on equity 2.27%
    • EPS (TTM) 19.54
    • Dividend yield 0.50%
    • Net profit/quarter (Cr) 72.93
    info icon alternate text

    STRIDES PHARMA SCI LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 582.65
    Operating Expense 575.77
    Net Profit 72.93
    Net Profit Margin (%) 12.51
    Earnings Per Share (EPS) 7.91
    EBITDA 139.00
    Effective Tax Rate (%) 13.95
    Particulars MAR 2026 (Values in Cr)
    Revenue 605.74
    Operating Expense 583.19
    Net Profit 16.35
    Net Profit Margin (%) 2.69
    Earnings Per Share (EPS) 1.77
    EBITDA 78.36
    Effective Tax Rate (%) 38.32
    Particulars DEC 2025 (Values in Cr)
    Revenue 553.63
    Operating Expense 522.07
    Net Profit 121.90
    Net Profit Margin (%) 22.01
    Earnings Per Share (EPS) 13.22
    EBITDA 184.45
    Effective Tax Rate (%) 9.57
    Particulars SEP 2025 (Values in Cr)
    Revenue 522.15
    Operating Expense 510.85
    Net Profit 32.04
    Net Profit Margin (%) 6.13
    Earnings Per Share (EPS) 3.48
    EBITDA 76.31
    Effective Tax Rate (%) -26.19
    Particulars JUN 2025 (Values in Cr)
    Revenue 498.62
    Operating Expense 483.96
    Net Profit 13.35
    Net Profit Margin (%) 2.67
    Earnings Per Share (EPS) 1.45
    EBITDA 68.99
    Effective Tax Rate (%) 18.65
    Particulars MAR 2026 (Values in Cr)
    Revenue 2180.14
    Operating Expense 2100.10
    Net Profit 183.64
    Net Profit Margin (%) 8.42
    Earnings Per Share (EPS) 19.92
    EBITDA 408.11
    Effective Tax Rate (%) 9.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 2139.42
    Operating Expense 2107.50
    Net Profit 2886.21
    Net Profit Margin (%) 134.90
    Earnings Per Share (EPS) 313.68
    EBITDA 308.60
    Effective Tax Rate (%) 24.24
    Particulars MAR 2024 (Values in Cr)
    Revenue 1866.12
    Operating Expense 1942.40
    Net Profit 44.55
    Net Profit Margin (%) 2.38
    Earnings Per Share (EPS) 4.89
    EBITDA 203.85
    Effective Tax Rate (%) -5.84
    Particulars MAR 2023 (Values in Cr)
    Revenue 1854.50
    Operating Expense 1988.32
    Net Profit 4.68
    Net Profit Margin (%) 0.25
    Earnings Per Share (EPS) 0.52
    EBITDA 167.54
    Effective Tax Rate (%) 107.22
    Particulars MAR 2022 (Values in Cr)
    Revenue 1979.00
    Operating Expense 2080.98
    Net Profit 180.19
    Net Profit Margin (%) 9.10
    Earnings Per Share (EPS) 20.08
    EBITDA 200.12
    Effective Tax Rate (%) -737.70
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 337.14
    ROE % 20.30
    ROCE % 17.68
    Total Debt to Total Equity 0.64
    EBITDA Margin 21.60
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 276.88
    ROE % 150.71
    ROCE % 14.28
    Total Debt to Total Equity 0.94
    EBITDA Margin 18.76
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 231.28
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.28
    EBITDA Margin 14.55
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 243.09
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.32
    EBITDA Margin 6.42
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 262.70
    ROE % -9.42
    ROCE % -4.44
    Total Debt to Total Equity 1.05
    EBITDA Margin -0.34
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 356.23
    ROE % 2.27
    ROCE % 4.81
    Total Debt to Total Equity 0.37
    EBITDA Margin 14.11
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 346.42
    ROE % 85.90
    ROCE % 4.62
    Total Debt to Total Equity 0.43
    EBITDA Margin 14.43
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 383.84
    ROE % 1.43
    ROCE % 2.40
    Total Debt to Total Equity 0.44
    EBITDA Margin 11.23
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 380.71
    ROE % 0.61
    ROCE % 1.87
    Total Debt to Total Equity 0.39
    EBITDA Margin 9.91
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 379.36
    ROE % 5.29
    ROCE % 1.87
    Total Debt to Total Equity 0.33
    EBITDA Margin 9.57
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 213.14
    Total Assets 6927.23
    Total Liabilities 6927.23
    Total Equity 3149.33
    Share Outstanding 9
    Price to Book Ratio 2.63
    Return on Assets (%) 8.02
    Return on Capital (%) 11.54
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 136.78
    Total Assets 6048.72
    Total Liabilities 6048.72
    Total Equity 2586.46
    Share Outstanding 9
    Price to Book Ratio 1.93
    Return on Assets (%) 59.40
    Return on Capital (%) 82
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.00
    Total Liabilities 0.00
    Total Equity 0.00
    Share Outstanding 0
    Price to Book Ratio 2.04
    Return on Assets (%) 0.00
    Return on Capital (%) 0
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 0.00
    Total Liabilities 0.00
    Total Equity 0.00
    Share Outstanding 0
    Price to Book Ratio 0.75
    Return on Assets (%) 0.00
    Return on Capital (%) 0
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 187.35
    Total Assets 6975.86
    Total Liabilities 6975.86
    Total Equity 2383.31
    Share Outstanding 8
    Price to Book Ratio 0.91
    Return on Assets (%) -6.59
    Return on Capital (%) -8.89
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 40.68
    Total Assets 5395.71
    Total Liabilities 5395.71
    Total Equity 3283.51
    Share Outstanding 9
    Price to Book Ratio 2.63
    Return on Assets (%) 3.40
    Return on Capital (%) 4.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 30.49
    Total Assets 5030.94
    Total Liabilities 5030.94
    Total Equity 3192.73
    Share Outstanding 9
    Price to Book Ratio 1.93
    Return on Assets (%) 57.36
    Return on Capital (%) 66.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 115.09
    Total Assets 5901.87
    Total Liabilities 5901.87
    Total Equity 3527.60
    Share Outstanding 9
    Price to Book Ratio 2.04
    Return on Assets (%) 0.75
    Return on Capital (%) 0.86
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 85.58
    Total Assets 5619.74
    Total Liabilities 5619.74
    Total Equity 3455.05
    Share Outstanding 9
    Price to Book Ratio 0.75
    Return on Assets (%) 0.08
    Return on Capital (%) 0.1
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 14.44
    Total Assets 5433.85
    Total Liabilities 5433.85
    Total Equity 3406.68
    Share Outstanding 8
    Price to Book Ratio 0.91
    Return on Assets (%) 3.31
    Return on Capital (%) 3.87
    Particulars MAR 2026 (Values in Cr)
    Net Income 668.68
    Cash from Operations 773.63
    Cash from Investing -173.03
    Cash from Financing -453.40
    Net change in Cash 76.07
    Free Cash Flow 1191.56
    Particulars MAR 2025 (Values in Cr)
    Net Income 3675.02
    Cash from Operations 617.33
    Cash from Investing -89.68
    Cash from Financing -642.58
    Net change in Cash -47.89
    Free Cash Flow 864.83
    Particulars MAR 2024 (Values in Cr)
    Net Income -62.72
    Cash from Operations 676.81
    Cash from Investing -150.25
    Cash from Financing -693.32
    Net change in Cash -142.50
    Free Cash Flow 794.96
    Particulars MAR 2023 (Values in Cr)
    Net Income -267.63
    Cash from Operations -43.23
    Cash from Investing 302.47
    Cash from Financing -213.92
    Net change in Cash 132.96
    Free Cash Flow 51.70
    Particulars MAR 2022 (Values in Cr)
    Net Income -652.51
    Cash from Operations -260.14
    Cash from Investing -118.73
    Cash from Financing 421.31
    Net change in Cash 44.76
    Free Cash Flow -116.75
    Particulars MAR 2026 (Values in Cr)
    Net Income 203.10
    Cash from Operations 279.14
    Cash from Investing -69.07
    Cash from Financing -198.93
    Net change in Cash 9.84
    Free Cash Flow 442.71
    Particulars MAR 2025 (Values in Cr)
    Net Income 2905.13
    Cash from Operations 298.96
    Cash from Investing -137.59
    Cash from Financing -370.31
    Net change in Cash -86.42
    Free Cash Flow 470.16
    Particulars MAR 2024 (Values in Cr)
    Net Income 40.99
    Cash from Operations -67.71
    Cash from Investing -69.56
    Cash from Financing 93.33
    Net change in Cash 9.76
    Free Cash Flow 8.70
    Particulars MAR 2023 (Values in Cr)
    Net Income -64.76
    Cash from Operations 141.92
    Cash from Investing -182.57
    Cash from Financing 10.81
    Net change in Cash 69.98
    Free Cash Flow 222.60
    Particulars MAR 2022 (Values in Cr)
    Net Income 21.50
    Cash from Operations -304.09
    Cash from Investing 18.77
    Cash from Financing 250.73
    Net change in Cash -13.17
    Free Cash Flow -235.92
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD. 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTANJAN HEALTH CARE LTD. 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 477.10 51.63 4.38 5068.90 118.35 552.90

    STRIDES PHARMA SCI LTD shareholding pattern

    Holding
    28.28%
    27.91%
    28.39%
    15.4%
    38.1%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    STRIDES PHARMA SCI LTD Technicals Summary

    1003.80 0.66 redarrow
    red-green-graph indicator
    12 Bearish
    4 Bullish
    • 5 Days 1003.70
    • 26 Days 1042.60
    • 10 Days 1016.50
    • 50 Days 1053.40
    • 12 Days 1021.00
    • 100 Days 1034.70
    • 20 Days 1035.20
    • 200 Days 978.40
    991.00 PIVOT
    First Support 970.20 First Resistance 1018.00 Second Support 943.20 Second Resistance 1038.80 Third Support 922.40 Third Resistance 1065.80
    RSI 40.89 ADX 49.84 MACD -21.63 Williams % R -70.22 Commodity Channel Index (CCI) -101.83
    Date 2026-08-07 Week 206022.00 Same Day 114109.00 Month 108349.00
    1 Year 0.61 3 Year 0.78
    Over 1 Month
    -11.02% down
    Over 1 Year
    25.74% down
    Over 3 Months
    -12.46% down
    Over 3 Years
    72.99% down
    Over 6 Months
    13.28% down
    Over 5 Years
    27.45% down

    STRIDES PHARMA SCI LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    31 Jul 2026 5.0 Final 31 Jul 2026 Equity shares
    22 Jul 2025 4.0 Final 22 Jul 2025 Equity shares
    09 Sep 2024 2.5 Final 09 Sep 2024 Equity shares
    04 Aug 2023 1.5 Final 04 Aug 2023 Equity shares
    05 Aug 2021 2.5 Final 06 Aug 2021 Equity shares
    24 Jul 2020 2.0 Final 27 Jul 2020 Equity shares
    22 Aug 2019 12.0 Interim 23 Aug 2019 Equity shares
    19 Jul 2019 3.0 Final 23 Jul 2019 Equity shares
    12 Sep 2018 2.0 Final 15 Sep 2018 Equity shares
    07 Sep 2017 4.5 Final 09 Sep 2017 Equity shares
    21 Jul 2016 4.0 Final 23 Jul 2016 Equity shares
    22 Jul 2015 3.0 Final 24 Jul 2015 Equity shares
    16 Oct 2014 105.0 Special 17 Oct 2014 Equity shares
    01 Sep 2014 5.0 Final 03 Sep 2014 Equity shares
    19 Dec 2013 500.0 Special 20 Dec 2013 Equity shares
    30 May 2013 2.0 Final 03 Jun 2013 Equity shares
    14 May 2012 2.0 Final 16 May 2012 Equity shares
    18 May 2011 1.5 Final 20 May 2011 Equity shares
    21 May 2010 1.5 Final 25 May 2010 Equity shares
    12 Jun 2007 2.0 Final 14 Jun 2007 Equity shares
    06 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    31 Jul 2026 5.0 Final 31 Jul 2026 Equity shares
    22 Jul 2025 4.0 Final 22 Jul 2025 Equity shares
    09 Sep 2024 2.5 Final 09 Sep 2024 Equity shares
    04 Aug 2023 1.5 Final 04 Aug 2023 Equity shares
    05 Aug 2021 2.5 Final 06 Aug 2021 Equity shares
    24 Jul 2020 2.0 Final 27 Jul 2020 Equity shares
    22 Aug 2019 12.0 Interim 23 Aug 2019 Equity shares
    19 Jul 2019 3.0 Final 23 Jul 2019 Equity shares
    12 Sep 2018 2.0 Final 15 Sep 2018 Equity shares
    07 Sep 2017 4.5 Final 09 Sep 2017 Equity shares
    21 Jul 2016 4.0 Final 23 Jul 2016 Equity shares
    22 Jul 2015 3.0 Final 24 Jul 2015 Equity shares
    16 Oct 2014 105.0 Special 17 Oct 2014 Equity shares
    01 Sep 2014 5.0 Final 03 Sep 2014 Equity shares
    19 Dec 2013 500.0 Special 20 Dec 2013 Equity shares
    30 May 2013 2.0 Final 03 Jun 2013 Equity shares
    14 May 2012 2.0 Final 16 May 2012 Equity shares
    18 May 2011 1.5 Final 20 May 2011 Equity shares
    21 May 2010 1.5 Final 25 May 2010 Equity shares
    12 Jun 2007 2.0 Final 14 Jun 2007 Equity shares
    06 Jun 2006 0.0 Final 01 Jan 0001 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Strides Pharma Science Ltd?

    Answer Field

    Strides Pharma Science Ltd share price is for NSE ₹ 1,003.80 & for BSE ₹ 1,007.05 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of Strides Pharma Science Ltd Share?

    Answer Field

    The market cap of Strides Pharma Science Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of Strides Pharma Science Ltd?

    Answer Field

    The 52 Week High and Low of Strides Pharma Science Ltd for NSE is ₹ 1,231.00 and ₹ 768.65 and for BSE is ₹ 1,231.45 and ₹ 769.60.

    What is 1 year return for Strides Pharma Science Ltd?

    Answer Field

    The 1 year returns on the stock has been 25.74%.

    What is the P/E Ratio of Strides Pharma Science Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for Strides Pharma Science Ltd share is 38.16.

    What is the PB ratio of Strides Pharma Science Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for Strides Pharma Science Ltd share is 356.23.

    How to Buy Strides Pharma Science Ltd Share?

    Answer Field

    You can trade in Strides Pharma Science Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Strides Pharma Science Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Strides Pharma Science Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Strides Pharma Science Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |